The five full-length ERβ variants, which result from alternative splicing of the last coding exon, deletion of coding exons, or alternative usage of untranslated exons and are named ERβ1–5, can be detected in various normal tissues, breast cancer tissues and breast cancer cell lines [32, 33]. This evidence concerns the gene ESR2 and breast carcinoma.